Recent Finacing
Recent Raise
ReCode Therapeutics is a Menlo Park–based clinical-stage genetic medicines company developing mRNA and gene-correction therapies delivered via its proprietary Selective Organ Targeting (SORT) lipid nanoparticle platform.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
